The cause of the non-reproducible advia centaur xp thcg result is unknown.Quality control and calibrator were acceptable at the time of the event.Given that the qc and calibration were acceptable, the issue is most likely with the sample itself.The sample may not have had sufficient time to clot before spinning or was not spun long enough which could lead to imprecision.The limitations section of the instructions for use states: "all in vitro assays can generate erroneous results, both clinically false positive results (test results suggesting a condition that is absent) and clinically false negative results (test results failing to identify a condition that is present).If an aberrant or abnormal result, as defined by the laboratory protocol, occurs, laboratory personnel should first make certain that the system is performing and is operated and maintained in accordance with the product labeling.The user should then follow the laboratory protocol for advising the clinician of a result that appears to have deviated from the norms established by the laboratory.Test results alone are not diagnoses of medical conditions.For example, low titer elevations of hcg can occur in normal nonpregnant subjects.A physician's diagnosis involves evaluation of the test result in conjunction with, and in the context of, the patient's medical history, physical examination, and other test results - sometimes in consultation with other medical experts." thcg reagent lot was not provided, therefore a udi # is not available.
|
Siemens filed mdr 1219913-2016-00219 on november 22, 2016 reporting an elevated advia centaur xp total hcg (thcg) result that was not elevated upon repeat testing.The reagent lot number and udi were not available at the time of filing.November 30, 2016 additional information: advia centaur thcg reagnet lot 32869285, expiration date 03/17/2017, (b)(4).The customer also provided information that the patient is a smoker.
|